Eli Lilly has not said why it is seeing this shortage The shortage will only affect vials of insulin, not the pens, which doctors hope will help alleviate some of the panic people may be experiencing.

Despite online claims, President Donald Trump’s executive orders did not include removing Medicare’s $35 monthly out-of-pocket price cap, which is set by law.

After years of preparation, Eli Lilly is on the brink of launching ... The Tempo system brings together a pre-filled insulin pen, the TempoSmart app and a recently-approved Smart Button device ...

When Eli Lilly last year started offering lower-priced vials of its blockbuster obesity drug Zepbound, which were previously ...

Two years ago, Eli Lilly started working with Dexcom ... app-based remote monitoring and alarm functions – in pen- and pump-based insulin systems that form the basis of the drugmaker’s ...

The global insulin delivery pen market is poised for remarkable growth, with its valuation projected to increase from USD ...

you may be eligible to pay as low as $25 for a one- or three-month supply of Zepbound,” Eli Lilly says. “One month is defined as 28 days and 4 pens. Three months is defined as 84 days and up ...

According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...

In 2023, the global disposable pen injectors market is expected to be worth USD 25.5 billion. The market is expected to reach USD 54.4 billion by 2033, expanding at a 7.9% CAGR throughout the forecast ...

The Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA Pharma through a collaboration with Eli Lilly (LLY). Launched in 2022, the collaboration aims to deliver a ...

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) have competed for decades. They're both leaders in the areas of insulin and broader diabetes drugs, where they've made significant breakthroughs ...

The official spokesperson for the Ministry of Health and Population Hossam Abdel-Ghaffar announced details on the extended-release for the first locally produced batch of insulin “Glargine ...